---
title: 'Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia:
  an Expert Consensus Statement From ERKNet and MetabERN'
date: '2024-12-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39698355/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241219170844&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Methylmalonic acidemias (MMAs) are rare inherited metabolic diseases
  with multiorgan involvement. Chronic kidney disease (CKD) is a common complication,
  leading to kidney failure, dialysis, and kidney transplantation (KT). The objective
  of these guidelines was to develop clinical practice recommendations focusing on
  specific aspects of the kidney management of this disease. Development of these
  clinical practice recommendations is an initiative of the European Reference Network
  for Rare ...
disable_comments: true
---
Methylmalonic acidemias (MMAs) are rare inherited metabolic diseases with multiorgan involvement. Chronic kidney disease (CKD) is a common complication, leading to kidney failure, dialysis, and kidney transplantation (KT). The objective of these guidelines was to develop clinical practice recommendations focusing on specific aspects of the kidney management of this disease. Development of these clinical practice recommendations is an initiative of the European Reference Network for Rare ...